Veterinary Infectious Disease Diagnostics Market To Reach USD 5.10 Bn By 2034

Overview

New York, NY – August 13 , 2025 : The Global Veterinary Infectious Disease Diagnostics Market is expected to grow from USD 2.34 Billion in 2024 to USD 5.10 Billion by 2034. This represents a CAGR of 8.1% from 2025 to 2034. North America dominated in 2024 with a 39.6% market share, generating USD 926.6 million in revenue. Growth is driven by increasing animal health concerns and demand for accurate diagnostics. Advancements in PCR, immunodiagnostics, and molecular diagnostics are enhancing detection of infectious diseases in companion animals and livestock, supporting faster and more reliable veterinary decision-making.

Veterinary diagnostic laboratories provide a wide range of tests for infectious agents, often offering multiple testing options for specific pathogens. Selecting the correct test, sample type, and animal is essential for accurate diagnosis. Sensitivity and specificity vary by test, and multiple tests may be required for reliable interpretation. In large populations like shelters or farms, diagnostic costs become a concern. Therefore, using aggregate or composite samples efficiently can help manage expenses while maintaining the accuracy needed for disease monitoring and control.

The market is expanding as veterinary clinics, reference laboratories, and point-of-care facilities adopt advanced diagnostic tools. Rising pet ownership and the need to control zoonotic diseases in livestock are key growth drivers. Governments and regulatory bodies are enforcing stricter disease control measures, increasing the demand for early detection. However, the high cost of diagnostic equipment and reagents poses a challenge, especially in emerging markets. Despite this, ongoing technological innovations are expected to offset some of these barriers in the coming years.

Artificial Intelligence is reshaping veterinary diagnostics by making tests faster, more accurate, and cost-effective. Innovations like Vetscan OptiCell and Vetscan Imagyst are transforming blood analysis and imaging processes. In September 2024, Zoetis Inc. announced the upcoming launch of the Vetscan OptiCell™, an AI-powered hematology analyzer. This cartridge-based tool delivers advanced Complete Blood Count (CBC) analysis, offering significant time and space savings. The new analyzer is expected to enhance clinic workflows, improve patient outcomes, and strengthen efficiency in veterinary healthcare practices.

AI integration is also improving urinalysis and imaging diagnostics, enabling veterinary teams to expand their diagnostic capabilities. By easing workloads, AI allows clinics to handle more cases without compromising quality. Connectivity solutions are enhancing data accessibility, giving veterinarians instant access to vital diagnostic results. This supports timely decision-making and better treatment outcomes. As AI-powered platforms and point-of-care solutions continue to evolve, the veterinary infectious disease diagnostics market is set to experience significant advancements, creating opportunities for efficiency, cost reduction, and improved animal health worldwide.

Key Takeaways

• In 2024, the global veterinary infectious disease diagnostics market generated US$ 2.34 billion, growing at 8.1% CAGR, and projected to hit US$ 5.10 billion by 2034.
• The technology segment is dominated by immunodiagnostics, including lateral flow assays and ELISA tests, which captured 49.1% market share in 2024.
• By animal type, companion animals lead the market with 57.5% share, surpassing livestock due to rising pet healthcare awareness and diagnostic advancements.
• Bacterial infections hold the largest share in infection type diagnostics, representing 39.8% of the total veterinary infectious disease diagnostics market in 2024.
• Reference laboratories are the top end-user category, accounting for 46.8% share in 2024, driven by advanced testing capabilities and accurate disease detection.
• North America emerged as the leading regional market in 2024, holding 39.6% share, supported by advanced veterinary infrastructure and growing pet care expenditure.

Regional Analysis

North America leads the global veterinary infectious disease diagnostics market with a 39.6% share. This growth is driven by high pet ownership, as over 67% of U.S. households have pets. Rising demand for veterinary services and diagnostics supports market expansion. The region benefits from advanced veterinary infrastructure, including modern clinics and diagnostic laboratories. Such facilities encourage the adoption of advanced diagnostic technologies. Additionally, strong awareness programs on zoonotic disease control and animal health contribute to the market’s continued growth in the coming years.

The market also benefits from innovative product launches. In November 2022, VolitionRx Limited, a multinational epigenetics company, introduced its Nu.Q Vet Cancer Screening Test in the U.S. A European launch is planned through Heska Corporation, a major global provider of advanced veterinary diagnostics. Heska’s diagnostic laboratory network will facilitate this rollout. The availability of such advanced tests is expected to boost diagnostic adoption. This will further strengthen North America’s leadership position in the global veterinary diagnostics industry.

Segmentation Analysis

The Immunodiagnostics segment leads the Veterinary Infectious Disease Diagnostics Market, holding 49.1% market share in 2024. Its popularity comes from affordability, speed, and ease of use. ELISA and lateral flow assays are widely adopted for detecting bacterial and viral infections in animals. These methods work well in both advanced labs and rural areas with limited resources. While PCR and other molecular diagnostics are gaining popularity for their high sensitivity, immunodiagnostics remains the preferred choice for many. Recent developments, like VolitionRx’s expanded agreement in Japan, strengthen this segment’s growth prospects.

The Companion Animals segment dominates the market with a 57.5% share, driven by rising pet ownership and greater awareness of animal health. Dogs, cats, and horses receive increasing veterinary care as owners invest in prevention and treatment. Pet insurance and welfare initiatives further support market growth. Companies like Ceva are launching projects to improve animal care and diagnostics. The demand for quick, accurate tests is growing, with immunodiagnostic and molecular solutions widely used. This segment is expected to remain strong due to continued innovation and increasing healthcare investment.

Bacterial infections hold the top position in infection type analysis, with a 39.8% market share. These infections are common in both livestock and companion animals, making rapid detection essential. A 2022 study highlighted high bacterial recovery rates, especially from diarrheal and skin samples in dogs. Conditions like bovine mastitis, kennel cough, and salmonella in poultry increase the need for reliable diagnostics. Methods such as PCR, ELISA, and lateral flow assays are frequently used. The high impact of bacterial diseases on animal health and agriculture drives sustained demand for advanced diagnostic solutions.

Reference Laboratories lead the market in the end user segment with 46.8% share. These facilities perform complex tests for various animal diseases using advanced technologies, including PCR and immunodiagnostics. They are essential for outbreak surveillance, epidemiological studies, and specialized diagnostics. Veterinarians and research organizations rely on them for accurate results, especially for rare or severe infections. Regulatory bodies often require certified lab results, reinforcing their market position. With ongoing technology upgrades and service expansion, reference laboratories are expected to maintain their dominance in veterinary infectious disease diagnostics.

Key Players Analysis

The Veterinary Infectious Disease Diagnostics market features leading players such as IDEXX Laboratories, Inc., Zoetis Inc., Thermo Fisher Scientific Inc., bioMérieux S.A., Neogen Corporation, Virbac, Randox Laboratories Ltd., INDICAL Bioscience GmbH, IDvet, Heska Corporation, QIAGEN N.V., Antech Diagnostics, Eurofins Technologies, QuidelOrtho, Fujifilm Wako Pure Chemical Corporation, Mindray Bio-Medical Electronics Co., Ltd., BioNote, Inc., Agrolabo S.p.A., Abbott Laboratories, and Danaher Corporation. These companies focus on innovative diagnostic solutions to improve disease detection and management in companion animals, livestock, and poultry across global markets.

IDEXX Laboratories, Inc. leads the market with a broad range of immunodiagnostics, molecular diagnostics, and point-of-care tools. Popular platforms like SNAP tests and VetTest deliver rapid, accurate results. Zoetis Inc. offers molecular diagnostics, immunodiagnostic assays, and reagents, serving both livestock and companion animals. Thermo Fisher Scientific Inc. provides PCR-based molecular diagnostics for precise disease detection. Their advanced tools support diagnostics in poultry, livestock, and companion animals, helping veterinarians improve disease control and enable faster, data-driven decisions.

Emerging Trends

• Growing Demand for Rapid and On-Site Testing: Veterinarians are increasingly using quick diagnostic kits that deliver results within minutes. This allows them to start treatment immediately when time is critical. Such tests are especially important in emergencies, where delays could lead to serious health risks for animals. On-site testing reduces the need for lab visits, saving both time and cost for pet owners and farmers. It also ensures that contagious diseases are contained faster. As more clinics adopt these kits, rapid diagnostics are becoming an essential part of veterinary practice, supporting better animal health and preventing the spread of infections.
• Shift Toward Molecular Diagnostics: Molecular diagnostic technologies, like PCR (Polymerase Chain Reaction), are gaining popularity in veterinary care. They offer high accuracy and can detect diseases at early stages, even before symptoms appear. This early detection helps veterinarians take timely action to prevent complications. PCR tests are also effective for identifying specific pathogens, which helps in selecting the right treatment. As technology costs fall, more clinics are adopting molecular diagnostics as part of routine testing. The precision and reliability of these tests make them an important tool for improving disease control and supporting animal health management strategies.
• Integration of AI and Digital Platforms: Artificial intelligence is transforming how veterinary diagnostic data is analyzed. AI tools can process results quickly and reduce the risk of human error. Many clinics now use cloud-based platforms to store and share diagnostic data securely. This makes it easier for veterinarians and labs to collaborate, even if they are in different locations. Faster analysis also means quicker decision-making for treatments. Over time, AI-driven platforms are expected to improve disease detection accuracy. The combination of AI and cloud technology is making veterinary diagnostics more efficient, reliable, and accessible to both urban and rural animal healthcare providers.
• Increased Awareness of Zoonotic Diseases: Zoonotic diseases are illnesses that can spread from animals to humans. This growing health concern is driving demand for early disease detection in animals. Pet owners, farmers, and public health authorities are more aware of the risks now than ever before. By diagnosing infections early, veterinarians can prevent outbreaks that could harm both animals and people. This is especially important for livestock and pets living close to humans. Governments and animal health organizations are also promoting testing as part of public safety measures. The focus on zoonotic disease control is making veterinary diagnostics a higher priority worldwide.
• Rising Use of Point-of-Care Devices for Field Testing: Portable veterinary diagnostic tools are becoming more common in farms and rural areas. These devices allow veterinarians to test animals on-site, even when full lab facilities are not available. This is especially useful for large-scale farms, where testing every animal in a central lab would be time-consuming. Point-of-care devices also provide faster results, allowing immediate treatment decisions. Farmers benefit from reduced downtime and better disease control. As these tools become more affordable and reliable, they are expected to play a bigger role in routine veterinary care, especially in regions with limited access to advanced labs.
• Focus on Preventive Healthcare: Preventive healthcare is gaining importance in veterinary practice. More pet owners and livestock managers are choosing routine screenings for their animals, even when they appear healthy. This approach helps detect infections before they spread or become severe. Early detection also reduces treatment costs and improves recovery chances. Veterinary clinics are promoting regular check-ups as part of responsible pet and farm management. By combining preventive care with advanced diagnostics, animal health professionals can protect herds, prevent outbreaks, and improve overall well-being. The shift toward prevention is shaping the future of veterinary infectious disease diagnostics.

Use Cases

• Companion Animal Clinics: Veterinary clinics use advanced diagnostic tests to quickly detect infections in pets like dogs and cats. A rapid test can confirm if a dog has parvovirus within minutes, allowing treatment to start immediately. This fast response can save lives and reduce the risk of the disease spreading to other pets. Clinics also test for other common conditions such as feline leukemia and heartworm disease. By identifying health problems early, veterinarians can create effective treatment plans. Pet owners benefit from faster answers, reduced stress, and better health outcomes for their animals. Rapid diagnostics make pet care more efficient and reliable.
• Livestock Health Management: Farmers use diagnostic tools to detect diseases in cattle, pigs, or poultry before they spread. Early detection helps prevent large-scale losses and keeps herds healthy. This is critical for protecting the food supply chain and ensuring meat, milk, and eggs remain safe for consumption. For example, testing for foot-and-mouth disease or avian influenza can stop outbreaks before they cause serious damage. Farmers also save money by avoiding unnecessary treatments. Regular screenings can be part of herd management plans. Quick and accurate diagnostics support animal welfare and help farms meet safety regulations while maintaining productivity.
• Wildlife Disease Surveillance: Conservation organizations use veterinary diagnostics to monitor wildlife health. They test for diseases that could harm endangered species or spread to livestock and humans. For example, tracking avian flu in wild birds helps prevent outbreaks in poultry farms. Early detection also supports ecological balance by protecting vulnerable animal populations. Portable diagnostic kits allow researchers to work in remote areas without access to full laboratories. By identifying and managing threats early, conservation teams can take quick action. This work is essential for protecting biodiversity, reducing cross-species disease risks, and ensuring the stability of natural ecosystems.
• Animal Shelters and Rescue Centers: Animal shelters and rescue centers test new arrivals for contagious diseases before admitting them. This prevents outbreaks and keeps other animals safe. Common tests include screenings for parvovirus, feline immunodeficiency virus, and kennel cough. Detecting illnesses early ensures that sick animals get treatment and are isolated if needed. Quick diagnostics also help shelters avoid unnecessary treatments, saving money and resources. Healthy animals can be placed for adoption faster, improving their chances of finding homes. With effective disease control, shelters maintain public trust and provide a safe environment for both animals and staff.
• Equine Health Checks: Racehorses and breeding horses undergo regular diagnostic screenings to detect infectious diseases. Conditions like equine influenza or strangles can impact performance and breeding success. Early detection allows owners and trainers to treat issues before they become serious. Testing also helps maintain competition standards by ensuring horses are healthy before races. Breeding programs benefit from healthy mares and stallions, improving foal quality. Portable diagnostic tools allow veterinarians to test horses on-site at stables or race tracks. By integrating regular health checks, the equine industry reduces disease risks, improves performance outcomes, and protects valuable investments in the animals.
• Export and Trade Compliance: Diagnostic testing ensures animals meet health requirements before they are shipped to other countries. Many nations have strict import rules to prevent the spread of diseases like rabies or brucellosis. Testing provides proof of an animal’s health status, avoiding delays or rejections at borders. Farmers, breeders, and exporters rely on accurate diagnostics to comply with these regulations. This process protects international markets and maintains trust between trading partners. Quick and reliable testing also helps reduce the risk of spreading diseases globally. By meeting compliance standards, exporters can expand their business opportunities while ensuring animal safety.

Conclusion

The veterinary infectious disease diagnostics market is set for strong growth, driven by rising awareness of animal health, better diagnostic technologies, and a greater focus on early detection. Advances in tools like PCR, immunodiagnostics, and AI-powered devices are making testing faster, more accurate, and easier to access.

Increasing pet ownership, livestock disease control needs, and strict health regulations are also boosting demand. While high equipment costs remain a challenge in some regions, ongoing innovation is helping to reduce barriers. With growing adoption in clinics, farms, and research settings, the market is expected to play a vital role in improving animal care, preventing disease outbreaks, and supporting global animal health standards.

Discuss your needs with our analyst

Please share your requirements with more details so our analyst can check if they can solve your problem(s)

Request a Sample Download PDF